PRODUCT LITERATURE
Triamcinolone in Asthma and Secondary Bronchospastic Pulmonary Emphysema
Triamcinolone possesses, in common with other clinically useful corticosteroids, the striking ability to curtail the allergic reaction irrespective of wide differences in precipitating factors and in responsiveness to other forms of therapy. Palliative effects in bronchial asthma have been induced promptly following the administration of comparatively small doses” and it is a recent observation that with a conservative approach to dosage, satisfactory relief of respiratory distress may be obtained
with few, if any, serious complications.
No other version available